H2BC12L and cancer: While the classically considered mode of action of these compounds is regarded as interfering with chromatin structure and regulating the accessibility of transcriptional complexes to the DNA[19], recent evidence suggests that modifying non-histone proteins contributes to the potent effects of deacetylase inhibitors in cancer cells[25,45].